What’s new: China’s drug regulatory agency said authorities seized a batch of fake versions of Pfizer’s Paxlovid antiviral pill as demand for Covid-19 treatments skyrockets amid limited supplies.
Some of the phony drugs did not contain valid ingredients or had illegally added other ingredients, China’s National Medical Products Administration said Monday in a statement. The cases are being handled by the public security department, the medicine regulator said.
